We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| BioNTech SE | NASDAQ:BNTX | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.15 | 1.25% | 93.39 | 60.00 | 239.00 | 93.54 | 91.60 | 93.42 | 663,328 | 05:00:10 |
From May 2021 to May 2024
By Matt Grossman
Pfizer Inc. has enrolled the first subjects in a study testing the coadministration of the company's Covid-19 booster shot along with Pfizer's 20-valent pneumococcal conjugate vaccine.
The study, which includes 600 people age 65 or older, will study the safety of giving the two shots together. Some people in the study will get both shots, while others will get just one of the two vaccines plus a placebo.
The trial's subjects were recruited from the cohort that participated in Pfizer's Phase 3 trial for its Covid-19 vaccine last year.
Pfizer developed its Covid-19 vaccine with BioNTech SE.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
May 24, 2021 07:07 ET (11:07 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year BioNTech Chart |
1 Month BioNTech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
